September 20, 2007 4:30 PM
- Text
Genes May Help Dieters' Longevity
- Adele's Grammy Comeback After Vocal Cord Surgery
- Treating Sleep Apnea in Kids Improves Behavior, Quality of Life
- Chemo May Not Harm Unborn Baby
- C-Sections Not Always Best for Small Babies
- CDC: Doctors Increasingly Prescribe Exercise
- Osteoporosis Medication Linked to Unusual Thigh Fractures
- More from WebMD »
generic DNA genetics chromosome helix gene genes genetic (iStockphoto)
(WebMD)
Scientists may have a new clue about how calorie restriction may lengthen life.
Previous research has linked calorie restriction to longevity, though many of those studies have been done in rodents and other short-lived species including worms, flies, and yeast.
Certain genes may be the link between calorie restriction and cell survival, a new study shows. Those genes, called SIRT3 and SIRT4, might eventually be targets for drugs to treat age-related diseases, according to Harvard Medical School's David Sinclair, PhD.
Sinclair's team studied a complex chemical chain reaction in which these genes nudge cells to live longer in the face of stress.
That stress came in the form of a two-day fast for rats studied by Sinclair and colleagues.
After the rats finished fasting, the researchers studied the rats' livers. They noticed that a protein called NAD+ was present at higher-than-normal levels in the rats' cellular powerhouses (mitochondria).
In earlier lab tests, the scientists had already linked increased NAD+ levels to the SIRT3 and SIRT4 genes.
Basically, those genes boost production of another chemical, which in turn boosts NAD+ levels, and the whole process hinges on the cells being stressed (in this case, by the rats' fasting).
The study, published in the journal Cell, doesn't prove that a two-day fast, or lengthier calorie restriction, will extend human life span. But the findings may help explain the inner workings of cells during calorie restriction.
"Theoretically, we can envision a small molecule that can increase levels of NAD, or SIRT3 and SIRT4 directly, in the mitochondria," Sinclair states in a Harvard Medical School news release. "Such a molecule could be used for many age-related diseases."
Sinclair is a co-founder of Sirtris Pharmaceuticals, which is developing drugs that target SIRT genes.
By Miranda Hitti
Reviewed by Louise Chang
©2007 WebMD, Inc. All rights reserved
Previous research has linked calorie restriction to longevity, though many of those studies have been done in rodents and other short-lived species including worms, flies, and yeast.
Certain genes may be the link between calorie restriction and cell survival, a new study shows. Those genes, called SIRT3 and SIRT4, might eventually be targets for drugs to treat age-related diseases, according to Harvard Medical School's David Sinclair, PhD.
Sinclair's team studied a complex chemical chain reaction in which these genes nudge cells to live longer in the face of stress.
That stress came in the form of a two-day fast for rats studied by Sinclair and colleagues.
After the rats finished fasting, the researchers studied the rats' livers. They noticed that a protein called NAD+ was present at higher-than-normal levels in the rats' cellular powerhouses (mitochondria).
In earlier lab tests, the scientists had already linked increased NAD+ levels to the SIRT3 and SIRT4 genes.
Basically, those genes boost production of another chemical, which in turn boosts NAD+ levels, and the whole process hinges on the cells being stressed (in this case, by the rats' fasting).
The study, published in the journal Cell, doesn't prove that a two-day fast, or lengthier calorie restriction, will extend human life span. But the findings may help explain the inner workings of cells during calorie restriction.
"Theoretically, we can envision a small molecule that can increase levels of NAD, or SIRT3 and SIRT4 directly, in the mitochondria," Sinclair states in a Harvard Medical School news release. "Such a molecule could be used for many age-related diseases."
Sinclair is a co-founder of Sirtris Pharmaceuticals, which is developing drugs that target SIRT genes.
By Miranda Hitti
Reviewed by Louise Chang
©2007 WebMD, Inc. All rights reserved
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Norovirus outbreak hits Rider University in N.J
- Chinese mom gives birth to 15-pound baby
- Marijuana-smoking motorists twice as likely to crash
- Electric shocks to brain may boost memory: Study
- America's sodium problem: Not from salty snacks?
- Caffeine inhalers - the next club drug?
- America's pets also have an obesity epidemic
- Measles patient at Super Bowl prompts health alert
- Skin cancer self-exam: What to look for (PHOTOS)
- Things You Didn't Know About Your Penis
- 4.5 million Americans over 50 have artificial knees
- PICTURES: 15 Shocking Sexual Fetishes
- Drinking soda raises risk for asthma, COPD: Study
- Let's Move! campaign turns 2 today: Is it working?
- Woman spotlights uterus didelphys on talk show
- Dr. Liar? Study finds dishonest docs common
Latest CBS News Headlines
on Facebook
on CBS News
- China: Syria veto won't hurt cooperation with US
- US Embassy to improve processing visas to Chinese
- Terror trial of accused Bali bomber starts Monday
- Thai prime minister's party seeks charter change
on Facebook
- Adele sings a cappella for Anderson Cooper
- Josh Powell had "incestuous" images on his home computer, authorities say
on CBS News






